Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Innate Immunity|March 10, 2015
Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunityKhalil Karimi, Yalda Karimi, Jeffrey Chan, et al.
The Journal of Clinical Investigation|February 3, 2004
TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infectionAnna Zganiacz, Michael Santosuosso, Jun Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2015
T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in MiceHeather VanSeggelen, Joanne A Hammill, Anna Dvorkin-Gheva, et al.
Journal of Virology|September 18, 2009
Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirusJonathan D Finn, Jennifer Bassett, James B Millar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
Potentiating cancer immunotherapy using an oncolytic virusByram W Bridle, Kyle B Stephenson, Jeanette E Boudreau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
Mucosally delivered dendritic cells activate T cells independently of IL-12 and endogenous APCsSarah McCormick, Michael Santosuosso, Cherrie-Lee Small, et al.
Cancer Immunology Research|October 8, 2024
Level of Expression of MHCI-Presented Neoepitopes Influences Tumor Rejection by Neoantigen-Specific CD8+ T CellsLi Deng, Scott R Walsh, Andrew Nguyen, et al.
Inflammation|April 25, 2024
Exosomes From Human Umbilical Cord Stem Cells Suppress Macrophage-to-myofibroblast Transition, Alleviating Renal FibrosisQitong Guo, Ping Li, Meiling Chen, et al.
Oncoimmunology|July 4, 2012
Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patientsA J Robert McGray, Dannie Bernard, Robin Hallett, et al.
Blood|January 18, 2013
Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8(+) T-cell recall responsesLiang Zhang, Byram W Bridle, Lan Chen, et al.
Pageof 9